Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer

Anticancer Research

Volumn 25, Issue 6 C, 2005, Pages 4455-4461

  Takehara, Akira ^a   Kawakami, Kazuyuki ^a   Ohta, Naohiro ^a   Oyama, Kaeko ^a   Ota, Yasuhiko ^a   Oda, Makoto ^a   Watanabe, Go ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

MTHFR polymorphism; Non small cell lung cancer; Prognosis; TS polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GENOMIC DNA; THYMIDYLATE SYNTHASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; VARIABLE NUMBER OF TANDEM REPEAT;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; THYMIDYLATE SYNTHASE;

EID: 28444435084     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nakagawa T, Otake Y, Yanagihara K, Miyahara R, Ishikawa S, Fukushima M, Wada H and Tanaka F: Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC). Lung Cancer 43: 145-149, 2004.
2. Allegra C: Thymidylate synthase levels: prognostic, predictive, or both?, J Clin Oncol 20: 1711-1713, 2002.
3. Danenberg PV: Thymidilate synthase - a target enzyme in cancer chemotherapy. Biochem Biophy Acta 473: 73-92, 1977.
4. Danenberg PV, Malli H and Swenson S: Thymidylate synthase inhibitors. Semin Oncol 26: 621-631, 1999.
5. Nakagawa T, Tanaka F, Otake Y, Yanagihara K, Miyahara R, Matsuoka K, Takata T, Yamada T, Fukushima M and Wada H: Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung. Lung Cancer 35: 165-170, 2002.
6. Horie N, Aiba H, Oguro K, Hojo H and Takeishi K: Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 20: 191-197, 1995.
7. Kawakami K, Omura K, Kanehira E and Watanabe Y: Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 19: 3249-3252, 1999.
8. Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J, Omura K, Watanabe G and Danenberg PV: Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 7: 4096-4101, 2001.
9. Ishida Y, Kawakami K, Tanaka Y, Kanehira E, Ohmura K and Watanabe G: Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer. Anticancer Res 22: 2805-2810, 2002.
10. Iacopetta B, Grieu F, Joseph D and Elsaleh H: A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer 85: 827-830, 2001.
11. Kawakami K and Watanabe G: Identification and functional : analysis of single nucleotide polymorphism in the tandem 1 repeat sequence of thymidylate synthase gene. Cancer Res 63: 6004-6007, 2003.
12. Mandola MV, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz HJ and Ladner RD: A novel single nucleotide polymorphism within the 5′tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res 63: 2898-2904, 2003.
13. Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong Y-P, Ingles SA, Sherrod A, Warren A, Tsao-Wei D, Groshen S and Lenz H-J: Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J 1: 65-70, 2001.
14. Villafranca E, Okruzhnov Y, Dominguez MA, Garcia-Foncillas J, Azinovic I, Martinez E, Illarramendi JJ, Arias F, Martinez Monge R, Salgado E, Angeletti S and Brugarolas A: Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J Clin Oncol 19: 1779-1786, 2001.
15. Etienne MC, Chazal M, Laurent-Puig P, Magne N, Rosty C, Formento JL, Francoual M, Formento P, Renee N, Chamorey E, Bourgeon A, Seitz JF, Delpero JR, Letoublon C, Pezet D and Milano G: Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J Clin Oncol 20: 2832-2843, 2002
16. Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S and Matsuda H: New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction. Int J Cancer 104: 790-795, 2003.
17. Trihn BN, Ong CN, Coetzee GA, Yu MC and Laird PW: Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111: 299-302, 2002.
18. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, Heijer M, Kluijtmans LAJ, Heuvel LP and Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113, 1995.
19. Shen H, Spitz MR, Wang LE, Hong WK and Wei Q: Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 10: 397-401, 2001.
20. Kawakami K, Omura K, Kanehira E and Watanabe Y: Methylenetetrahydrofolate reductase polymorphism is associated with folate pool in gastrointestinal cancer tissue. Anticancer Res 21: 285-290, 2001.
21. Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Watanabe G and Iacopetta B: The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res 9: 5860-5865, 2003.
22. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997.
23. Iwasaki A, Shirakusa T, Shiraishi T and Yamamoto S: Results of video-assisted thoracic surgery for stage I/II non-small cell lung cancer. Eur J Cardiothorac Surg 26: 158-164, 2004.